Clinical Trial Update: Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of olanzapine in patients with Borderline Personality Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Personality Disorder

Drugs mentioned

• Zyprexa (olanzapine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Borderline Personality Disorder | Phase 3 | Status: COMPLETED